Impact of hematogones on the long-term outcomes of single-unit cord blood transplantation for adult patients

References

• Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–3820.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–498.
   PubMed Web of Science ®Google Scholar
• Danby R, Rocha V. Improving engraftment and immune reconstitution in umbilical cord blood transplantation. Front Immunol. 2014;5:68.
   PubMed Web of Science ®Google Scholar
• Lucchini G, Perales MA, Veys P. Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy. 2015;17:711–722.
   PubMed Web of Science ®Google Scholar
• McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498–2507.
   PubMed Web of Science ®Google Scholar
• Sevilla DW, Colovai AI, Emmons FN, et al. Hematogones: a review and update. Leuk Lymphoma. 2010;51:10–19.
   PubMed Web of Science ®Google Scholar
• Chantepie SP, Cornet E, Salaün V, et al. Hematogones: an overview. Leuk Res. 2013;37:1404–1411.
   PubMed Web of Science ®Google Scholar
• McKenna DH, Rupp C, Wagner J, et al. Increased lymphoblast-like cells following umbilical cord blood stem cell transplantation do not predict recurrent acute leukemia. Leukemia. 2002;16:2171–2172.
   PubMed Web of Science ®Google Scholar
• Shono Y, Toubai T, Ota S, et al. Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation – a case report. Clin Lab Haematol. 2006;28:351–354.
   PubMedGoogle Scholar
• Mattei D, Bassan R, Mordini N, et al. Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient. Bone Marrow Transplant. 2007;40:283–285.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Gascón A, Martínez-Cuadrón D, et al. Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2012;18:388–395.
   PubMed Web of Science ®Google Scholar
• Chantepie SP, Salaün V, Parienti JJ, et al. Hematogones: a new prognostic factor for acute myeloblastic leukemia. Blood. 2011;117:1315–1318.
   PubMed Web of Science ®Google Scholar
• Zheng J, Du W, Yao J, et al. Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy. Eur J Clin Invest. 2013;43:1140–1146.
   PubMed Web of Science ®Google Scholar
• Chu SC, Wang TF, Su YC, et al. Prognostic significance of flow cytometric residual disease, dysregulated neutrophils/monocytes, and hematogones in adult acute myeloid leukemia in first remission. Int J Hematol. 2014;99:296–304.
   PubMed Web of Science ®Google Scholar
• Honebrink T, Dayton V, Burke MJ, et al. Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012;18:930–936.
   PubMed Web of Science ®Google Scholar
• Shima T, Miyamoto T, Kikushige Y, et al. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. Blood. 2013;121:840–848.
   PubMed Web of Science ®Google Scholar
• Christopeit M, Heiland A, Binder M, et al. Impact of physiological BM CD10 + CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML. Bone Marrow Transplant. 2013;48:1257–1259.
   PubMed Web of Science ®Google Scholar
• Doki N, Haraguchi K, Hagino T, et al. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2015;94:2055–2060.
   PubMed Web of Science ®Google Scholar
• Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1:710–719.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Ooi J, Tomonari A, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007;109:1322–1330.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452–458.
   PubMed Web of Science ®Google Scholar
• Konuma T, Kato S, Ooi J, et al. Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission. Biol Blood Marrow Transplant. 2014;20:396–401.
   PubMed Web of Science ®Google Scholar
• Konuma T, Kato S, Oiwa-Monna M, et al. Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide. Leuk Lymphoma. 2015;56:1148–1150.
   PubMed Web of Science ®Google Scholar
• Arakawa-Hoyt J, Dao MA, Thiemann F, et al. The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrow. Bone Marrow Transplant. 1999;24:1167–1176.
   PubMed Web of Science ®Google Scholar
• Niehues T, Rocha V, Filipovich AH, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. Br J Haematol. 2001;114:42–48.
   PubMed Web of Science ®Google Scholar
• Komanduri KV, St John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;110:4543–4551.
   PubMed Web of Science ®Google Scholar
• Rénard C, Barlogis V, Mialou V, et al. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol. 2011;152:322–330.
   PubMed Web of Science ®Google Scholar
• Kanda J, Chiou LW, Szabolcs P, et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:1664–1676.
   PubMed Web of Science ®Google Scholar
• Servais S, Lengline E, Porcher R, et al. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:507–517.
   PubMed Web of Science ®Google Scholar
• Nakatani K, Imai K, Shigeno M, et al. Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation. Bone Marrow Transplant. 2014;49:1155–1161.
   PubMed Web of Science ®Google Scholar